Sagittarius Life Science Corp (TPEX:3205)
52.30
+2.00 (3.98%)
Mar 24, 2026, 1:30 PM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.53 billion as of March 24, 2026. Its market cap has increased by 224.01% in one year.
Market Cap
3.53B
Enterprise Value
3.38B
Revenue
346.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.30
Market Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.53B, an increase of 1,123.69%. That is a compound annual growth rate of 13.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 3.53B | 1.95% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 4.20B |
| Energenesis Biomedical CO.,LTD. | 3.94B |
| Formosa Pharmaceuticals | 3.90B |
| ACRO Biomedical | 3.78B |
| Genovate Biotechnology | 3.45B |
| Shine-On BioMedical | 3.33B |
| SYN-TECH Chem. & Pharm. | 3.21B |
| BRIM Biotechnology | 3.15B |